Hikal Ltd

NSE: HIKAL · BSE: 524735 · Pharmaceuticals & Biotechnology · 28 announcements

Share price: ₹226.43
Market cap: ₹2,792 Cr
Revenue (annual): ₹1,713 Cr
Net profit (annual): ₹-48.80 Cr
P/E (TTM): -82.6×Sector 47.4×
Promoter holding: 68.85%+0.00% QoQ
FII holding: 0.98%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 5 Other Announcement 4 Annual General Meeting 4 Management Change 3 Financial Results 3 Results Update 2 Board Meeting Date 2 Results Correction 1 Production Started 1 Legal & Regulatory 1 Dividend 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

6 Aug 2026 14:48 IST NSE

Financial Results

Hikal Q1 FY27 Results: Net Loss of ₹7.4 Cr, Loss Narrows

Hikal Ltd reported revenue from operations of ₹402.8 Cr (+5.9% YoY) and a net loss of ₹7.4 Cr for Q1 FY27.

Key figure: Net loss ₹7.4 Cr

Open full results → Read the filing ↗

27 May 2026 16:04 IST NSE

Financial ResultsAlfa Alert

Hikal Q4 FY26 Results: Net Profit ₹14.4 Cr, Down 71.3% YoY

Hikal Ltd reported revenue from operations of ₹519.4 Cr (-6.0% YoY) and net profit of ₹14.4 Cr (-71.3% YoY) for Q4 FY26.

Key figure: Net profit ₹14.4 Cr · -71.3% YoY

Open full results → Read the filing ↗

27 May 2026 16:03 IST NSE

Financial Results

Hikal Financial Results

Hikal Limited reported its FY2025-26 audited financial results and recommended a 20% final dividend. The board also approved appointing Sandip Parikh as an Independent Director.

Read the filing ↗